KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Depreciation & Amortization (CF) (2016 - 2025)

Petmed Express' Depreciation & Amortization (CF) history spans 16 years, with the latest figure at $2.4 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 51.26% year-over-year to $2.4 million; the TTM value through Dec 2025 reached $9.0 million, up 31.69%, while the annual FY2025 figure was $7.0 million, 0.24% changed from the prior year.
  • Depreciation & Amortization (CF) reached $2.4 million in Q4 2025 per PETS's latest filing, up from $2.3 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $2.4 million in Q4 2025 to a low of $636000.0 in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $1.4 million, with a median of $1.6 million recorded in 2024.
  • Peak YoY movement for Depreciation & Amortization (CF): soared 122.84% in 2023, then decreased 10.4% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $710000.0 in 2021, then surged by 32.54% to $941000.0 in 2022, then skyrocketed by 88.1% to $1.8 million in 2023, then dropped by 10.4% to $1.6 million in 2024, then skyrocketed by 51.26% to $2.4 million in 2025.
  • Per Business Quant, the three most recent readings for PETS's Depreciation & Amortization (CF) are $2.4 million (Q4 2025), $2.3 million (Q3 2025), and $2.3 million (Q2 2025).